UnitedHealth Group (NYSE:UNH) Price Target Cut to $337.00 by Analysts at Barclays

UnitedHealth Group (NYSE:UNH - Free Report) had its price objective decreased by Barclays from $350.00 to $337.00 in a report published on Wednesday morning,Benzinga reports. Barclays currently has an overweight rating on the healthcare conglomerate's stock.

UNH has been the subject of several other reports. Piper Sandler reduced their price target on UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a research report on Tuesday, June 3rd. Royal Bank Of Canada reduced their price target on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. Argus cut UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Monday, April 21st. Bank of America cut UnitedHealth Group from a "buy" rating to a "neutral" rating and reduced their price target for the company from $560.00 to $350.00 in a research report on Wednesday, May 14th. Finally, KeyCorp cut their price objective on UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating for the company in a research report on Monday, June 2nd. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $415.00.

UnitedHealth Group Stock Up 1.4%

NYSE UNH traded up $4.30 during trading on Wednesday, hitting $303.81. The company's stock had a trading volume of 9,789,082 shares, compared to its average volume of 7,703,876. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The company has a market cap of $275.60 billion, a PE ratio of 12.72, a P/E/G ratio of 1.46 and a beta of 0.45. The business's 50 day simple moving average is $314.52 and its 200-day simple moving average is $440.88. UnitedHealth Group has a fifty-two week low of $248.88 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same period last year, the firm earned $6.91 EPS. On average, equities analysts anticipate that UnitedHealth Group will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were paid a dividend of $2.21 per share. The ex-dividend date was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.91%. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is 37.02%.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Kristen Gil purchased 3,700 shares of the firm's stock in a transaction dated Thursday, May 15th. The shares were acquired at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the purchase, the director directly owned 3,818 shares in the company, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the firm's stock in a transaction dated Wednesday, May 14th. The stock was acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the purchase, the director owned 6,033 shares in the company, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 109,408 shares of company stock valued at $31,607,768 in the last three months. Company insiders own 0.28% of the company's stock.

Hedge Funds Weigh In On UnitedHealth Group

Several large investors have recently modified their holdings of UNH. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at $26,000. Hurley Capital LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at $28,000. Bayforest Capital Ltd raised its holdings in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after buying an additional 48 shares during the period. Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at $30,000. Finally, Clal Insurance Enterprises Holdings Ltd raised its holdings in shares of UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after buying an additional 50 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.